MedImmune Message Board - Msg: 19513313

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MedImmune

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (260)	11/18/2003 10:28:21 AM
From: tuck	Read Replies (1) of 416

>>7:23AM MEDI cut to Sell at Deutsche; target $15 25.58: -- Update -- Deutsche Securities downgrades MedImmune to Sell from Hold and cuts their target to $15 from $31 after the co lowered guidance (6:11); firm believes FluMist has been mispriced for the mkt (FluMist was introduced at a price of $46 vs $8 for the conventional flu shot), and as a result firm believes that weak FluMist sales will persist; firm also thinks visibility on the co's pipeline is poor.<< Courtesy of briefing.com. Deutsche only half right here. Yeah, FluMist sucks. Pipeline visibility may be poor, but not for long. I think $15 is a bit much, and so does the market so far: not even close to firesale status today. Weisel was way ahead Deutsche on this. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next